Andrew ElBardissi
Partner at Deerfield Management
Andrew Elbardissi
Partner at Deerfield Management
New York, New York
Overview
Work Experience
Partner
2017 - Current
Deerfield Management is a healthcare company that works across investment, information, and philanthropy.
Board Member
2022
Board Member
2022
Aurion Biotechnologies is a clinical-stage biotech company.
Raised $120,000,000.00 from Visionary Venture Fund, Alcon, Petrichor Healthcare Capital Management, Deerfield, Falcon Vision and Flying L Partners.
Board Member
2021
Board Member
2021
Board Member
2020
Encodia is a biotech company that develops the next generation of protein analysis tools.
Raised $75,000,000.00 from ARCH Venture Partners, Northpond Ventures, Decheng Capital, Google Ventures, Biomatics Capital Partners, Nan Fung Life Sciences, Deerfield, Alexandria Venture Investments and Tao Capital Partners.
Board Member
2020
Board Member
2020
Board Member
2020
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
Raised $91,050,001.00 from Deerfield Management, Lightstone Ventures, Sante Ventures, Genesis Capital, Arboretum Ventures and Deerfield.
Board Member
2019
Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Raised $183,100,000.00 from Google Ventures, Cormorant Asset Management, Invus, Deerfield, Qiming Venture Partners USA and Third Rock Ventures.